Abstract
A 14-year-old boy with X-linked chronic granulomatous disease developed severe invasive pulmonary aspergillosis. He was treated with itraconazole and amphotericin B. However, he deteriorated with progressive pulmonary lesions. Burkholderia cepacia was isolated from his bronchoalveolar lavage. Finally, he was given granulocyte transfusions. Following this procedure, his condition rapidly worsened leading to respiratory failure. His lung biopsy demonstrated organizing pneumonia at his right middle lobe. Then, a methylprednisolone pulse therapy was initiated together with the administration of appropriate antibiotics and adequate amounts of amphotericin B. Dramatically, his condition improved. Therefore, a methylprednisolone pulse therapy with appropriate antimicrobial drugs seems to be beneficial for severe pulmonary insufficiency in this type of patients.
Copyright 1999 S. Karger AG, Basel
MeSH terms
-
Adolescent
-
Antifungal Agents / administration & dosage
-
Aspergillosis / complications
-
Aspergillosis / diagnosis
-
Aspergillosis / drug therapy*
-
Burkholderia Infections / complications
-
Burkholderia Infections / diagnosis
-
Burkholderia Infections / drug therapy*
-
Burkholderia cepacia / isolation & purification*
-
Drug Therapy, Combination
-
Follow-Up Studies
-
Fungemia / complications
-
Fungemia / diagnosis
-
Fungemia / drug therapy*
-
Glucocorticoids / administration & dosage
-
Granulomatous Disease, Chronic / complications
-
Granulomatous Disease, Chronic / diagnosis
-
Humans
-
Lung Diseases, Fungal / complications
-
Lung Diseases, Fungal / diagnosis
-
Lung Diseases, Fungal / drug therapy*
-
Male
-
Methylprednisolone / administration & dosage*
-
Pulmonary Valve Insufficiency / drug therapy*
-
Pulmonary Valve Insufficiency / etiology
-
Pulse Therapy, Drug
-
Treatment Outcome
Substances
-
Antifungal Agents
-
Glucocorticoids
-
Methylprednisolone